AI Analysis

How does MSCL.TO make money? Does MSCL.TO have pricing power? What's the Earnings Whisper? Will MSCL.TO profit more as the business scales? What is MSCL.TO's management track record? Is MSCL.TO's current price justified?

Satellos Bioscience Inc.

CAD 13.51 +$5.11 (+60.83%)

TSX · 14 Sep 2026 19:59 UTC

Previous Close

CAD 13.2

Day Range

CAD 13.51CAD 14

Year Range

CAD 7.32CAD 18.98

Market Cap

281.43M

AVG Volume

19.61K

Trailing/Forward PE

-4.9/-

PEG ratio

27.08

Dividend Yield

Next Earnings Date

2026-11-12

Primary Exchange

Toronto Stock Exchange

Net Income (USD) · TTM

MSCL.TO Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
26 Q2	-34.93M
26 Q1	-28.45M
25 Q4	-25M
25 Q3	-23.69M
25 Q2	-26.92M
25 Q1	-27.35M
24 Q4	-28.1M
24 Q3	-28.53M
24 Q2	-23.05M
24 Q1	-21.13M

Operating Income (USD) · TTM

MSCL.TO Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
26 Q2	-35.94M
26 Q1	-30.14M
25 Q4	-26.58M
25 Q3	-26.62M
25 Q2	-25.72M
25 Q1	-26.03M
24 Q4	-27.81M
24 Q3	-26.24M
24 Q2	-25.67M
24 Q1	-22.05M

EBITDA (USD) · TTM

MSCL.TO EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
26 Q2	-35.93M
26 Q1	-30.22M
25 Q4	-26.65M
25 Q3	-24.98M
25 Q2	-28.06M
25 Q1	-27.65M
24 Q4	-28.08M
24 Q3	-28.52M
24 Q2	-22.99M
24 Q1	-20.96M

Cash Flows (USD) · TTM

MSCL.TO Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
26 Q2	-28.76M
26 Q1	-25.78M
25 Q4	-23.72M
25 Q3	-24.15M
25 Q2	-24.4M
25 Q1	-25.21M
24 Q4	-24.98M
24 Q3	-22.61M
24 Q2	-22.24M
24 Q1	-20.46M

EPS (USD) · TTM

MSCL.TO EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
26 Q2	-1.98
26 Q1	-1.8
25 Q4	-1.73
25 Q3	-1.69
25 Q2	-2.24
25 Q1	-2.49
24 Q4	-2.78
24 Q3	-3.04
24 Q2	-2.46
24 Q1	-2.45

Expenses (USD) · TTM

MSCL.TO Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
26 Q2	35.89M
26 Q1	28.51M
25 Q4	23.42M
25 Q3	22.41M
25 Q2	21.5M
25 Q1	23.64M
24 Q4	27.47M
24 Q3	26.15M
24 Q2	25.7M
24 Q1	22.09M

Shares Outstanding (USD) · TTM

MSCL.TO Shares Outstanding (USD) · TTM by quarter
Period	Shares Outstanding (USD) · TTM
26 Q2	-2.49M
26 Q1	-3.32M
25 Q4	-3.23M
25 Q3	-2.7M
25 Q2	-2.16M
25 Q1	-2.02M
24 Q4	-1.93M
24 Q3	-2.34M
24 Q2	-2.85M
24 Q1	-2.52M

Free Cash Flow Yield

MSCL.TO Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-14.36%
Sep 26	-14.69%
Sep 26	-15.54%
Aug 26	-16.05%
Aug 26	-14.25%
Aug 26	-14.5%
Aug 26	-14.2%
Jul 26	-14%
Jul 26	-14.13%
Jul 26	-15.95%
Jul 26	-14.63%
Jul 26	-18.21%
Jun 26	-21.34%
Jun 26	-26.63%
Jun 26	-26.76%
Jun 26	-26.08%
May 26	-20.94%
May 26	-22.19%
May 26	-21.19%
May 26	-20.45%
May 26	-19.63%
Apr 26	-21.5%
Apr 26	-17.63%
Apr 26	-23.46%
Apr 26	-25.88%
Mar 26	-27.94%
Mar 26	-23.47%
Mar 26	-21.64%
Mar 26	-14.49%
Feb 26	-13.88%
Feb 26	-15.19%
Feb 26	-14.98%
Feb 26	-14.75%
Jan 26	-15.24%
Jan 26	-17.19%
Jan 26	-21.82%
Jan 26	-24.04%
Jan 26	-28.3%
Dec 25	-29.07%
Dec 25	-28.91%
Dec 25	-29.28%
Dec 25	-29.38%
Nov 25	-28.04%
Nov 25	-29.11%
Nov 25	-27.36%
Nov 25	-29%
Oct 25	-25.91%
Oct 25	-27.69%
Oct 25	-24.96%
Oct 25	-24.93%
Oct 25	-24.83%
Sep 25	-32.11%
Sep 25	-33.24%
Sep 25	-31.42%
Sep 25	-31.85%
Aug 25	-34.81%
Aug 25	-35.62%
Aug 25	-35.6%
Aug 25	-36.69%
Aug 25	-38.11%
Jul 25	-37.19%
Jul 25	-35.35%
Jul 25	-35.87%
Jul 25	-33.89%
Jun 25	-25.97%
Jun 25	-27.39%
Jun 25	-27.9%
Jun 25	-26.43%
May 25	-23.18%
May 25	-19.82%
May 25	-23.91%
May 25	-22.83%
May 25	-22.83%
Apr 25	-23.91%
Apr 25	-23.54%
Apr 25	-23.91%
Apr 25	-23.18%
Mar 25	-25.01%
Mar 25	-25.98%
Mar 25	-21.74%
Mar 25	-23.81%
Feb 25	-22.73%
Feb 25	-25.65%
Feb 25	-27.4%
Feb 25	-25.32%
Jan 25	-24.1%
Jan 25	-22.99%
Jan 25	-24.4%
Jan 25	-23.53%
Jan 25	-22.73%
Dec 24	-22.41%
Dec 24	-23.2%
Dec 24	-20.33%
Dec 24	-24.34%
Nov 24	-28.17%
Nov 24	-26.29%
Nov 24	-23.2%
Nov 24	-23.2%
Nov 24	-23.76%
Oct 24	-24.34%

Price to Book

MSCL.TO Price to Book by quarter
Period	Price to Book
Sep 26	2.54
Sep 26	2.48
Sep 26	2.35
Aug 26	2.27
Aug 26	2.56
Aug 26	2.51
Aug 26	2.57
Jul 26	2.6
Jul 26	2.58
Jul 26	2.29
Jul 26	2.49
Jul 26	2
Jun 26	4.01
Jun 26	3.21
Jun 26	3.2
Jun 26	3.28
May 26	4.08
May 26	3.85
May 26	4.04
May 26	4.18
May 26	4.36
Apr 26	3.98
Apr 26	4.85
Apr 26	3.65
Apr 26	3.3
Mar 26	2.54
Mar 26	3.03
Mar 26	3.28
Mar 26	4.9
Feb 26	5.12
Feb 26	4.68
Feb 26	4.74
Feb 26	4.82
Jan 26	4.66
Jan 26	4.13
Jan 26	3.25
Jan 26	2.95
Jan 26	2.51
Dec 25	2.19
Dec 25	2.2
Dec 25	2.17
Dec 25	2.17
Nov 25	2.27
Nov 25	2.19
Nov 25	2.33
Nov 25	2.19
Oct 25	2.46
Oct 25	2.3
Oct 25	2.55
Oct 25	2.55
Oct 25	2.56
Sep 25	1.88
Sep 25	1.82
Sep 25	1.93
Sep 25	1.9
Aug 25	1.74
Aug 25	1.7
Aug 25	1.7
Aug 25	1.65
Aug 25	1.59
Jul 25	1.63
Jul 25	1.71
Jul 25	1.69
Jul 25	1.79
Jun 25	1.42
Jun 25	1.34
Jun 25	1.32
Jun 25	1.39
May 25	1.59
May 25	1.86
May 25	1.54
May 25	1.61
May 25	1.61
Apr 25	1.54
Apr 25	1.56
Apr 25	1.54
Apr 25	1.59
Mar 25	4.39
Mar 25	4.23
Mar 25	5.05
Mar 25	4.61
Feb 25	4.83
Feb 25	4.28
Feb 25	4.01
Feb 25	4.34
Jan 25	4.56
Jan 25	4.78
Jan 25	4.5
Jan 25	4.67
Jan 25	4.83
Dec 24	3.4
Dec 24	3.29
Dec 24	3.75
Dec 24	3.13
Nov 24	2.71
Nov 24	2.9
Nov 24	3.29
Nov 24	3.29
Nov 24	3.21
Oct 24	3.13

No video analysis for this stock yet. Request one from our team.

News: MSCL.TO

globenewswire.com · 17 Jun 2026

Satellos Bioscience Announces Results of Annual Meeting of Shareholders

TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) ("Satellos" or the "Company"), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, announced today the results of its Annual Meeting of Shareholders held June 17, 2026 (the "Meeting").

AI Analysis

Satellos Bioscience Inc.

Video analysis: MSCL.TO

News: MSCL.TO

Satellos Bioscience Announces Results of Annual Meeting of Shareholders

Similar companies